Beta Bionics (BBNX) Shares Outstanding (Weighted Average) (2023 - 2026)

Beta Bionics' Shares Outstanding (Weighted Average) history runs 4 years deep, the most recent figure standing at $44.4 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) rose 44.67% year-over-year to $44.4 million; the TTM figure through Mar 2026 stood at $44.4 million (up 44.67% YoY), while the FY2024 annual figure was $6.4 million, up 20.01% from the prior year.
• Shares Outstanding (Weighted Average) came in at $44.4 million for Q1 2026 at Beta Bionics, up from $39.3 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $44.4 million in Q1 2026 to a low of $5.3 million in Q4 2023.
• A 4-year average of $20.2 million and a median of $6.7 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
• Across the five-year window, Shares Outstanding (Weighted Average) grew 20.01% in 2024 and surged 507.42% in 2025, its largest moves.
• Beta Bionics' Shares Outstanding (Weighted Average) stood at $5.3 million in 2023, then climbed by 20.01% to $6.4 million in 2024, then soared by 517.34% to $39.3 million in 2025, then advanced by 13.09% to $44.4 million in 2026.
• According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods registered $44.4 million, $39.3 million, and $37.1 million for Q1 2026, Q3 2025, and Q2 2025 respectively.

Peer Comparison